| 000 | 00813nab a2200229 ib4500 | ||
|---|---|---|---|
| 001 | D0001J000939 | ||
| 003 | DOH | ||
| 005 | 20231122103836.0 | ||
| 008 | 231122t ||||| |||| 00| 0 eng d | ||
| 100 | 1 | _aHui, Zheng | |
| 245 |
_aProgress towards elimination of mother-to-child transmission of hepatitis B virus infection in China : _ba modelling analysis / _cBy: Zheng Hui [and ten others] |
||
| 580 | _aBulletin of the World Health Organization 2021, 99(1) , 10-18 | ||
| 650 | 2 | _aHepatitis B | |
| 650 | 2 |
_aImmunoglobulins _vtherapeutic use |
|
| 650 | 2 | _aInfant | |
| 650 | 2 |
_aInfectious Disease Transmission, Vertical _vprevention & control |
|
| 650 | 2 | _aPregnancy | |
| 650 | 2 | _aPregnancy Complications | |
| 650 | 2 |
_aInfectious _vprevention & control |
|
| 650 | 2 |
_aTenofovir _vtherapeutic use |
|
| 942 | _cJA | ||
| 999 |
_c6266 _d6266 |
||